Cost-Effectiveness of Ibrutinib and Rituximab for the...

Cost-Effectiveness of Ibrutinib and Rituximab for the Relapsed or Refractory Chronic Lymphocytic Leukemia in China

Yang, F, Kumar, A, Rojanasarot, S, Schommer, JC, Shao, R
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.04.198
Date:
May, 2018
File:
PDF, 77 KB
english, 2018
Conversion to is in progress
Conversion to is failed